---
input_text: '[Wilson disease]. Wilson disease is an autosomal recessive inherited
  disorder of human copper metabolism that leads to neurological symptoms and hepatic
  damage of variable degree. The affected gene ATP7B encodes a hepatic copper transport
  protein, which plays a key role in human copper metabolism. Clinical symptoms are
  complex with neurologic symptoms such as tremor, dysarthria, psychiatric disorders
  etc., predominant hepatic disease or mixed forms. Copper deposition in the liver
  results in acute liver failure, chronic hepatitis or liver cirrhosis. Early recognition
  by means of clinical, biochemical or genetic examination and early initiation of
  therapy with chelators or zinc-salts are essential for outcome and prognosis. Liver
  transplantation is an alternative in cases with acute and chronic liver failure
  and cures the hepatic disease. Frequent monitoring of drug therapy, adverse effects,
  and compliance is critical for the prognosis of the disease.'
raw_completion_output: |-
  primary_disease: Wilson disease

  medical_actions: initiation of therapy with chelators; zinc-salts therapy; liver transplantation; monitoring of drug therapy

  symptoms: neurological symptoms; hepatic damage; tremor; dysarthria; psychiatric disorders; acute liver failure; chronic hepatitis; liver cirrhosis

  chemicals: chelators; zinc-salts

  action_annotation_relationships: initiation of therapy with chelators TREATS neurological symptoms IN Wilson disease; initiation of therapy with chelators TREATS hepatic damage IN Wilson disease; zinc-salts therapy TREATS neurological symptoms IN Wilson disease; zinc-salts therapy TREATS hepatic damage IN Wilson disease; liver transplantation TREATS acute liver failure IN Wilson disease; liver transplantation TREATS chronic hepatitis IN Wilson disease; liver transplantation TREATS liver cirrhosis IN Wilson disease
prompt: |+
  From the text below, extract the following entities in the following format:

  subject_extension: <A chemical or drug mentioned in the relationship between the medical action and the symptom, for example, "analgesic agent therapy" has the aspect "analgesic">
  object_extension: <An optional term describing some specific aspect of the object, e.g. "analgesic agent therapy" has the aspect "analgesic">
  subject: <The medical action. For example: blood transfusion, radiation therapy, cardiac catheterization, pulse oximetry, otoscopy>
  predicate: <The relationship type between the medical action and the symptom, usually TREATS or PREVENTS.>
  object: <A sign or symptom associated with the disease and targeted by the medical action. For example, Low serum calcitriol, hypoplasia of the thymus, chronic cough, aortic stiffness, low pulse pressure>
  qualifier: <The primary disease the relationship is about, or specifically the disease the symptom is related to. For example, Beck-Fahrner syndrome, hereditary retinoblastoma, progeria, diabetes mellitus, infectious otitis media>
  subject_qualifier: <An optional qualifier or modifier for the subject of the statement, e.g. "high dose" or "intravenously administered">
  object_qualifier: <An optional qualifier or modifier for the object of the statement, e.g. "severe" or "with additional complications">


  Text:
  liver transplantation TREATS liver cirrhosis IN Wilson disease

  ===

extracted_object:
  primary_disease: MONDO:0010200
  medical_actions:
    - initiation of therapy with chelators
    - zinc-salts therapy
    - MAXO:0001175
    - monitoring of drug therapy
  symptoms:
    - neurological symptoms
    - hepatic damage
    - HP:0001337
    - HP:0001260
    - HP:0000708
    - HP:0006554
    - HP:0200123
    - HP:0001394
  chemicals:
    - CHEBI:38161
    - zinc-salts
  action_annotation_relationships:
    - subject: initiation of therapy
      predicate: TREATS
      object: neurological symptoms
      qualifier: MONDO:0010200
      subject_extension: CHEBI:38161
    - subject: initiation of therapy
      predicate: TREATS
      object: hepatic damage
      qualifier: MONDO:0010200
      subject_extension: CHEBI:38161
    - subject: MAXO:0001298
      predicate: TREATS
      object: neurological symptoms
      qualifier: MONDO:0010200
      subject_extension: zinc-salts
    - subject: MAXO:0001298
      predicate: TREATS
      object: hepatic damage
      qualifier: MONDO:0010200
      subject_extension: zinc-salts
    - subject: MAXO:0001175
      predicate: TREATS
      object: HP:0006554
      qualifier: MONDO:0010200
    - subject: <liver transplantation>
      predicate: <TREATS>
      object: <chronic hepatitis>
      qualifier: <Wilson disease>
      subject_qualifier: <>
      object_qualifier: <>
      subject_extension: <liver transplantation>
      object_extension: <chronic hepatitis>
    - subject: MAXO:0001175
      predicate: TREATS
      object: HP:0001394
      qualifier: MONDO:0010200
named_entities:
  - id: MONDO:0010200
    label: Wilson's disease
  - id: MAXO:0001175
    label: Liver transplantation
  - id: HP:0001695
    label: Cardiac arrest
  - id: HP:0001685
    label: Myocardial fibrosis
  - id: HP:0001663
    label: Ventricular fibrillation
  - id: CHEBI:28694
    label: Copper
  - id: CHEBI:18248
    label: Iron
  - id: HP:0002910
    label: abnormal liver functions
  - id: HP:0001394
    label: cirrhosis
  - id: CHEBI:27363
    label: zinc
  - id: CHEBI:50868
    label: penicillamine
  - id: MAXO:0000016
    label: Cell therapy
  - id: MAXO:0001001
    label: Gene therapy
  - id: CHEBI:30703
    label: Tetrathiomolybdate (TTM)
  - id: HP:0006554
    label: acute liver failure
  - id: CHEBI:35176
    label: Zinc sulphate
  - id: CHEBI:35475
    label: NSAIDs
  - id: MAXO:0009095
    label: zinc therapy
  - id: MAXO:0001298
    label: therapy
  - id: HP:0006579
    label: neonatal jaundice
  - id: HP:0001409
    label: portal hypertension
  - id: HP:0030151
    label: cholangitis
  - id: HP:0002612
    label: congenital hepatic fibrosis
  - id: MONDO:0013282
    label: alpha-1-antitrypsin deficiency
  - id: HP:0001903
    label: anemia
  - id: HP:0001410
    label: liver dysfunction
  - id: CHEBI:39501
    label: trientine
  - id: MAXO:0000070
    label: Hepatic transplantation
  - id: HP:0001399
    label: Hepatic failure
  - id: HP:0004448
    label: fulminant hepatic failure
  - id: HP:0003256
    label: coagulopathy (international normalized ratio >2.0)
  - id: HP:0004445
    label: hepatic encephalopathy (HE)
  - id: HP:0002480
    label: hepatic encephalopathy
  - id: CHEBI:35341
    label: Steroids
  - id: CHEBI:33281
    label: Antibiotics
  - id: MONDO:0100193
    label: End-stage liver disease
  - id: HP:0100626
    label: End-stage liver disease
  - id: HP:0100660
    label: dyskinesia
  - id: HP:0100022
    label: Movement disorders
  - id: HP:0001337
    label: Tremor
  - id: HP:0001332
    label: Dystonia
  - id: MONDO:0019542
    label: Acute liver failure (ALF)
  - id: CHEBI:27385
    label: CCL4
  - id: MAXO:0000127
    label: Genetic testing
  - id: CHEBI:7959
    label: D-penicillamine
  - id: MAXO:0001017
    label: Vaccination
  - id: HP:0001541
    label: Ascites
  - id: HP:0012398
    label: Peripheral edema
  - id: HP:0001260
    label: dysarthria
  - id: HP:0000708
    label: psychiatric disorders
  - id: HP:0200123
    label: chronic hepatitis
  - id: CHEBI:38161
    label: chelators
